Doutremepuich C - Search Results

1

[Artificial blood: the future of blood transfusion? I. Hemoglobin solutions].

Guyot M, Doutremepuich C. Guyot M, et al. Among authors: doutremepuich c. J Pharm Belg. 1990 Jan-Feb;45(1):20-8. J Pharm Belg. 1990. PMID: 2185356 Review. French.

2

[Artificial blood: the future of blood transfusion? II. Blood substitutes other than hemoglobin solutions].

Guyot M, Doutremepuich C. Guyot M, et al. Among authors: doutremepuich c. J Pharm Belg. 1990 May-Jun;45(3):196-206. J Pharm Belg. 1990. PMID: 2205716 Review. French.

3

Role of bone marrow in the development of thrombosis. A study of the curative and prophylactic action of heparin and heparin fragment (CY 222).

Doutremepuich C, Guyot M, Doutremepuich F, De Seze O, Masse A, Toulemonde F. Doutremepuich C, et al. Among authors: doutremepuich f. Thromb Res. 1989 May 15;54(4):369-75. doi: 10.1016/0049-3848(89)90095-9. Thromb Res. 1989. PMID: 2548301 No abstract available.

4

Laboratory control of heparin and heparin fragment treatment: an experimental study.

Doutremepuich C, Lalanne MC, Guyot M, Doutremepuich F, De Sèze O, Toulemonde F. Doutremepuich C, et al. Among authors: doutremepuich f. Semin Thromb Hemost. 1989 Oct;15(4):373-7. doi: 10.1055/s-2007-1002733. Semin Thromb Hemost. 1989. PMID: 2554497 No abstract available.

5

Could thrombus age be a modulator of heparin or L.M.W.H. activities?

Doutremepuich C, Lalanne MC, Doutremepuich F, Guyot M, De Sèze O. Doutremepuich C, et al. Among authors: doutremepuich f. Thromb Res. 1989 Aug 15;55(4):407-17. doi: 10.1016/0049-3848(89)90049-2. Thromb Res. 1989. PMID: 2554523

6

Comparative pharmacology of low molecular weight heparins: implications of manufacturing processes on biological effects.

Doutremepuich C, Guyot M, Lalanne MC, Deharo E, Walenga JM, Fareed J. Doutremepuich C, et al. Thromb Res. 1989 Aug 15;55(4):419-26. doi: 10.1016/0049-3848(89)90050-9. Thromb Res. 1989. PMID: 2554524

7

Antithrombotic activity of recombinant hirudin in the rat: a comparative study with heparin.

Doutremepuich C, Deharo E, Guyot M, Lalanne MC, Walenga J, Fareed J. Doutremepuich C, et al. Thromb Res. 1989 Jun 1;54(5):435-45. doi: 10.1016/0049-3848(89)90213-2. Thromb Res. 1989. PMID: 2772867

8

[Low molecular weight heparins].

Doutremepuich C, Lalanne MC, Guyot M, Doutremepuich F, Fernandez G, De Seze O, Deharo E, Vairel EG, Quilichini R. Doutremepuich C, et al. Among authors: doutremepuich f. Ann Pharm Fr. 1989;47(3):109-16. Ann Pharm Fr. 1989. PMID: 2561387 Review. French.

9

Template bleeding time after ingestion of ultra low dosages of acetyl salicylic acid in healthy subjects. Preliminary study.

Doutremepuich C, Pailley D, Anne MC, de Sèze O, Paccalin J, Quilichini R. Doutremepuich C, et al. Thromb Res. 1987 Nov 15;48(4):501-4. doi: 10.1016/0049-3848(87)90406-3. Thromb Res. 1987. PMID: 3445231 No abstract available.

10

What is the effect of acetylsalicylic acid at ultra low dose on the interaction platelets/vessel wall?

Lalanne MC, Doutremepuich C, de Sèze O, Belon P. Lalanne MC, et al. Among authors: doutremepuich c. Thromb Res. 1990 Nov 1;60(3):231-6. doi: 10.1016/0049-3848(90)90184-e. Thromb Res. 1990. PMID: 2084952 No abstract available.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

125 results

Search Page

Filters